In today’s fast-paced world, where stress and anxiety often hinder a good night’s sleep, many people seek natural remedies to improve their sleep quality. One such solution that has been gaining popularity is Levagen®+. This innovative supplement, derived from Palmitoylethanolamide (PEA), offers a range of benefits that can help promote better sleep. This blog will explore how Levagen®+ works and why it might solve your sleep troubles.
Understanding Levagen®+: What Is It?
Levagen+ is a branded form of Palmitoylethanolamide (PEA), a naturally occurring fatty acid amide found in the body. PEA has been studied extensively for its anti-inflammatory, analgesic, and neuroprotective properties. Levagen®+ takes the benefits of PEA a step further by enhancing its bioavailability through a process known as LipiSperse® technology, which ensures better absorption and effectiveness in the body.
How Levagen+ Promotes Better Sleep
Reduces Pain: Chronic pain is a common culprit behind poor sleep. PEA’s analgesic properties can help reduce pain, allowing for more comfortable and uninterrupted sleep. Research has shown that PEA can help reduce pain and discomfort, improving sleep quality (reference: Gabrielsson et al., 2016).
Alleviates Stress: Stress is a major contributor to sleep disturbances. Levagen®+ has been found to influence the endocannabinoid system, which plays a crucial role in regulating mood and stress responses. By modulating this system, Levagen®+ may help reduce feelings of stress, creating a more relaxed state that is conducive to sleep (reference: Petrosino et al., 2016).
Supports Neuroprotection: Levagen®+ has neuroprotective properties that can help protect nerve cells from damage, ensuring the proper functioning of the nervous system. This is particularly important for sleep, as a well-functioning nervous system is essential for regulating sleep cycles and providing restful sleep (reference: Impellizzeri et al., 2014).
Enhances Relaxation: Levagen®+ has been found to promote relaxation by supporting the production of calming neurotransmitters. These neurotransmitters, such as GABA, reduce brain activity and promote sleep (reference: Skaper et al., 2014).
Clinical Evidence Supporting Levagen+ for Sleep
Several studies have explored the potential of PEA and Levagen®+ in improving sleep quality. For instance, a study published in the Journal of Sleep Research found that participants who took PEA experienced significant improvements in sleep quality, including reduced sleep latency (the time it takes to fall asleep) and fewer nighttime awakenings (reference: Gatti et al., 2012).
Another study highlighted the role of PEA in reducing symptoms of sleep disorders, particularly in individuals suffering from chronic pain. The study participants reported better sleep patterns and overall sleep satisfaction after incorporating PEA into their daily regimen (reference: Costa et al., 2008).
How to Incorporate Levagen®+ into Your Routine
Levagen®+ is typically available in supplement form, making it easy to incorporate into your daily routine. To maximize its sleep-enhancing effects, it is recommended to take Levagen®+ before bedtime. However, as with any supplement, it is advisable to consult with a healthcare professional before starting a new regimen, especially if you have underlying health conditions or are taking other medications.
By incorporating Levagen+ into your nightly routine, you can take a step towards better sleep and overall well-being.
References:
Gabrielsson, L., Mattsson, S., Fowler, C. J. (2016). Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety, and efficacy. Neurotherapeutics, 13(2), 366-372.
Petrosino, S., Di Marzo, V. (2016). The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. British Journal of Pharmacology, 173(7), 1173-1188.
Impellizzeri, D., Bruschetta, G., Cordaro, M., et al. (2014). Micronized palmitoylethanolamide reduces inflammation and pain in inflammatory bowel disease. Journal of Neuroinflammation, 11, 88.
Skaper, S. D., Facci, L., Fusco, M., et al. (2014). Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. Inflammopharmacology, 22(2), 79-94.
Gatti, A., Lazzari, M., Gianfelice, V., et al. (2012). Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis. Pain Medicine, 13(8), 1121-1130.
Costa, B., Trovato, A. E., Comelli, F., et al. (2008). The endogenous fatty acid amide, palmitoylethanolamide, has anti-inflammatory and neuroprotective properties. Journal of Neuroinflammation, 5, 29.